Cognitive efficiency declines over time in adults with Type 1 diabetes: Effects of micro- and macrovascular complications

Diabetologia

Volumn 46, Issue 7, 2003, Pages 940-948

  Ryan, C M ^a   Geckle, M O ^a   Orchard, T J ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Adults; Cognitive dysfunction; Macrovascular complications; Microvascular complications; Type 1 diabetes

Indexed keywords

ADULT; ARTICLE; AUTONOMIC NEUROPATHY; COGNITIVE DEFECT; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MEMORY; MICROANGIOPATHY; PATHOGENESIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; PROBLEM SOLVING; PROLIFERATIVE RETINOPATHY; PSYCHOMOTOR ACTIVITY; SYSTOLIC BLOOD PRESSURE; VASCULAR DISEASE;

ADULT; AGE OF ONSET; COGNITION DISORDERS; DIABETES MELLITUS, TYPE 1; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; INTELLIGENCE TESTS; MALE; MICROCIRCULATION; PSYCHOMOTOR PERFORMANCE; REFERENCE VALUES; REGRESSION ANALYSIS;

EID: 0043071350     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-003-1128-2     Document Type: Article

References (61)

1. Biessels G-J (1999) Cerebral complications of diabetes: Clinical findings and pathogenetic mechanisms. Neth J Med 54:35-45
2. Deary IJ, Langan SJ, Graham KS, Hepburn D, Frier BM (1992) Recurrent severe hypoglycemia, intelligence, and speed of information processing. Intelligence 16:337-359
3. Sachon C, Grimaldi A, Digy JP, Pillon B, Dubois B, Thervet F (1992) Cognitive function, insulin-dependent diabetes and hypoglycaemia. J Intern Med 231:471-475
4. Wredling R, Levander S, Adamson U, Lins PE (1990) Permanent neuropsychological impairment after recurrent episodes of severe hypoglycaemia in man. Diabetologia 33:152-157
5. Ryan CM, Williams TM, Orchard TJ, Finegold DN (1992) Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes 41:107-113
6. Perros P, Deary IJ, Sellar RJ, Best JJK, Frier BM (1997) Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care 20:1013-1018
7. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving H (1991) Evidence for diabetic encephalopathy. Diabet Med 8:162-167
8. 99mTc-HMPAO SPET in type 1 diabetic patients with no clinical history of cerebrovascular disease. Eur J Nucl Med 24:1507-1513
9. Perros P, Deary IJ (1999) Long-term effects of hypoglycaemia on cognitive function and the brain in diabetes. In: Frier BM, Fisher BM (eds) Hypoglycaemia in clinical diabetes. Wiley, Chichester, pp 187-210
10. Deary I, Crawford J, Hepburn DA, Langan SJ, Blackmore LM, Frier BM (1993) Severe hypoglycemia and intelligence in adult patients with insulin-treated diabetes. Diabetes 42:341-344
11. Austin EJ, Deary IJ (1999) Effects of repeated hypoglycemia on cognitive function. Diabetes Care 22:1273-1277
12. Diabetes Control and Complications Trial Research Group (1996) Effects of intensive diabetes therapy on neuropsychological function in adults in the Diabetes Control and Complications Trial. Ann Intern Med 124:379-388
13. Reichard P, Berglund B, Britz A, Levander S, Rosenqvist U (1991) Hypoglycemic episodes during intensified insulin treatment: increased frequency but no effect on cognitive function. J Intern Med 229:9-16
14. Chabriat H, Sachon C, Levasseur M, Grimaldi A, Pappata S, Rougemont D, Masure MC, De Rocondo A, Samson Y (1994) Brain metabolism after recurrent insulin-induced hypoglycemic episodes: A PET study. J Neurol Neurosurg Psychiatry 57:1360-1365
15. Kramer L, Fasching P, Madl C, Schneider B, Damjancic P, Waldhäusl W, Irsigler K, Grimm G (1998) Previous episodes of hypoglycemic coma are not associated with permanent cognitive brain dysfunction in IDDM patients on intensive insulin treatment. Diabetes 47:1909-1914
16. Ryan CM, Williams TM, Finegold DN, Orchard TJ (1993) Cognitive dysfunction in adults with Type 1 (insulin-dependent) diabetes mellitus of long duration: effects of recurrent hypoglycaemia and other chronic complications. Diabetologia 36:329-334
17. Orchard TJ, Dorman JS, Maser RE, Becker DJ, Drash AL, Ellis D, Laporte RE, Kuller LH (1990) Prevalence of complications in IDDM by sex and duration: Pittsburgh Epidemiology of Complications Study II. Diabetes 39:1116-1124
18. Orchard TJ, Forrest KY-Z, Kuller LH, Becker DJ (2001) Lipid and blood pressure treatment goals for Type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes Care 24:1053-1059
19. American Diabetes Association (1999) Screening for Type 2 diabetes. Diabetes Care 22:S20-S23
20. Borhani NO, Kass EH, Langford HG, Payne GH, Remington RD, Stamler J (1976) The hypertension detection and follow-up program. Prev Med 5:207-215
21. Maser RE, Nielsen VK, Bass EB, Manjoo Q, Dorman JS, Kelsey SF, Becker DJ, Orchard TJ (1989) Measuring diabetic neuropathy: Assessment and comparison of clinical examination and quantitative sensory testing. Diabetes Care 12:270-275
22. Diabetes Control and Complications Trial Research Group (1986) The Diabetes Control and Complications Trial (DCCT): design and methodologic considerations for the feasibility phase. Diabetes 35:530-545
23. Early Treatment of Diabetic Retinopathy Study Coordinating Center (1980) Manual of operations. University of Maryland School of Medicine, Baltimore, MD
24. Diabetes Control and Complications Trial Research Group (1988) Factors in development of diabetic neuropathy: Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes 37:476-481
25. Stella P, Ellis D, Maser RE, Orchard TJ (2000) Cardiac autonomic neuropathy (expiration and inspiration ratio) in type 1 diabetes: Incidence and predictors. J Diabetes Complications 14:1-6
26. Ryan CM (1994) Measures of cognitive function. In: Bradley C (ed.) Handbook of psychology and diabetes. Harwood, Chur, Switzerland, pp 191-219
27. Mitrushina MN, Boone KB, D'Elia LF (1999) Handbook of normative data for neuropsychological assessment. Oxford University Press, New York
28. Derogatis LR (1983) SCL-90-R manual: administration, scoring & procedures. Clinical Psychometric Research, Towson, MD
29. McNair DM, Lorr M, Droppleman LF (1981) EDITS manual for the profile of mood states. Educational and Industrial Service, San Diego, CA
30. Ryan C, Vega A, Longstreet C, Drash L (1984) Neuropsychological changes in adolescents with insulin-dependent diabetes mellitus. J Consult Clin Psychol 52:335-342
31. Ryan CM, Geckle MO (2000) Circumscribed cognitive dysfunction in middle-aged adults with type 2 diabetes. Diabetes Care 23:1486-1493
32. Stewart RJ, Liolitsa D (1999) Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 16:93-112
33. Strachan MWJ, Deary IJ, Ewing FME, Frier BM (1997) Is Type 2 (non-insulin dependent) diabetes mellitus associated with an increased risk of cognitive dysfunction? Diabetes Care 20:438-445
34. Miller CD, Phillips LS, Ziemer DC, Gallina DL, Cook CB, El-Kebbi IM (2001) Hypoglycemia in patients with Type 2 diabetes mellitus. Arch Intern Med 161:1653-1659
35. Fontbonne A, Ducimetiere P, Berr C, Alperovitch A (2001) Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 24:366-370
36. Gregg EW, Yaffe K, Cauley JA, Rolka DB, Blackwell TL, Narayan KM, Cummings SR (2000) Is diabetes associated with cognitive impairment and cognitive decline among older women? Arch Intern Med 160:174-180
37. Knopman DS, Boland LL, Mosley T, Howard G, Liao D, Szklo M, McGovern PG, Folsom AR, ARIC Study Investigators (2001) Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 56:42-48
38. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L (1999) The role of APOE ε4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 282:40-46
39. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJK, Wardlaw JM, Deary IJ, Frier BM (2003) Cognitive ability and brain structure in type 1 diabetes: Relation to microangiopathy and preceding severe hypoglycemia. Diabetes 52:149-156
40. Wong TY, Klein R, Sharrett AR, Nieto FJ, Boland LL, Couper DJ, Mosley TH, Klein BEK, Hubbard LD, Szklo M (2002) Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: the Atherosclerosis Risk in Communities Study. Stroke 33:1487-1492
41. Wong TY, Klein R, Sharrett AR, Couper DJ, Klein BEK, Liao D-P, Hubbard LD, Mosley TH, ARIC Investigators (2002) Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288:67-74
42. Cameron NE, Eaton SEM, Cotter MA, Tesfaye S (2001) Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988
43. Price JC, Kelley DE, Ryan CM, Meltzer CC, Drevets WC, Mathis CA, Mazumdar S, Reynolds CF (2002) Evidence of increased serotonin-1A receptor binding in type 2 diabetes: a positron emission tomography study. Brain Res 927:97-103
44. Friedman EA (1999) Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications. Diabetes Care 22:B65-B71
45. Swan GE, DeCarli C, Miller BL, Reed T, Wolf PA, Jack LM, Carmelli D (1998) Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology 51:986-993
46. Strassburger TL, Lee H-C, Daly EM, Szczepanik J, Krausuki JS, Mentis MJ, Salerno JA, DeCarli C, Schapiro MB, Alexander GE (1997) Interactive effects of age and hypertension on volumes of brain structures. Stroke 28:1410-1417
47. Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson L-A, Nilsson L, Persson G, Odén A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145
48. Elias MF, Robbins MA, Elias PK, Streeten DHP (1998) A longitudinal study of blood pressure in relation to performance on the Wechsler Adult Intelligence Scale. Health Psychol 17:486-493
49. Elias PK, Elias MF, D'Agostino RB, Cupples LA, Wilson PW, Silbershatz H, Wolf PA (1997) NIDDM and blood pressure as risk factors for poor cognitive performance. Diabetes Care 20:1388-1395
50. Kilander L, Nyman H, Boberg M, Hansson L, Lithell H (1998) Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 31:780-786
51. Jennings JR, Muldoon MF, Ryan CM, Mintun MA, Meltzer CC, Townsend DW, Sutton-Tyrrell K, Shapiro AP, Manuck SB (1998) Cerebral blood flow in hypertensive patients: an initial report of reduced and compensatory blood flow responses during performance of two cognitive tasks. Hypertension 31:1216-1222
52. Longstreth WT, Manolio TAAA, Burke GL, Bryan N, Jungreis CA, Enright PL, O'Leary D, Fried L (1996) Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the Cardiovascular Health Study. Stroke 27:1274-1282
53. Sierra C, Sierra A de la, Mercader JM, Gómez-Angelats E, Urbano-Márquez A, Coca A (2002) Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 20:519-524
54. Leaper SA, Murray AD, Lemmon HA, Staff RT, Deary IJ, Crawford JR, Whalley LJ (2001) Neuropsychologic correlates of brain white matter lesions depicted on MR images: 1921 Aberdeen birth cohort. Radiology 221:51-55
55. Groot JC de, Leeuw F-E de, Oudkerk M, Gijn J van, Hofman A, Jolles J, Breteler MMB (2000) Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol 47:145-151
56. Miller EM (1994) Intelligence and brain myelination: a hypothesis. Pers Individ Diff 17:803-832
57. Marstrand JR, Garde E, Rostrup E, Ring P, Rosenbaum S, Mortensen EL, Larsson HBW (2002) Cerebral perfusion and cerebrovascular reactivity are reduced in white matter hyperintensities. Stroke 33:972-976
58. Filley CM (2001) The behavioral neurology of white matter. Oxford University Press, Oxford, UK
59. Virtaniemi J, Laakso M, Kärjä J, Nuutinen J, Karjalainen S (1993) Auditory brainstem latencies in type 1 (insulin-dependent) diabetic patients. Am J Otolaryngol 14:413-418
60. Kurita A, Katayama K, Mochio S (1996) Neurophysiological evidence for altered higher brain functions in NIDDM. Diabetes Care 19:361-364
61. Pfefferbaum A, Sullivan EV, Hedehus M, Lim KO, Adalsteinsson E, Moseley M (2000) Age-related decline in brain white matter anisotropy measured with spatially corrected echo-planar diffusion tensor imaging. Magn Reson Med 44:259-266